Funder: National Scleroderma Foundation
Due Dates (Anticipated): September 2027 (Application deadline)
Funding Amounts: Up to $200,000 over three years; up to $66,667 annually, including indirect costs
Summary: Supports promising new investigators entering scleroderma research and developing projects likely to lead to independent research grants.
Key Information: Applicants must not have previously served as principal investigator on national, private, or government grants, except fellowships.
Description
The National Scleroderma Foundation’s New Investigator Grant supports promising investigators holding faculty or equivalent positions who wish to pursue careers in scleroderma research. It facilitates entry into the field and supports projects likely to lead to individual research project grants, while advancing understanding of the disease and improving treatments.
The program supports basic, clinical, and health services research. Topics include lung disease, pediatric scleroderma, vascular and other clinical manifestations, therapeutic modalities, end-organ damage, animal models, immunology, endothelial cell and fibroblast biology, cell signaling, matrix and stem cell biology, epidemiology, gender and genetic factors, quality of life, and health care delivery. Peer review emphasizes scientific and technical merit, innovation, and the strength of the research approach.
